✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹470 Cr.
P/E
42.30

Key Ratios

Market cap
Market cap
470 Cr
PE
PE
42.30
Prom Holding
Prom Holding
75.00 %
ROE (%)
ROE (%)
4.90
ROCE (%)
ROCE (%)
8.92
Div Yield (%)
Div Yield (%)
-
Sales
Sales
150 Cr
OPM (%)
OPM (%)
10.59 %
Debt to Equity
Debt to Equity
0.33
Institutions
Institutions
9.34 %
Individual < 2 lac
Individual < 2 lac
4.48 %
No. of Shareholders
No. of Shareholders
6,928

About

Bafna Pharmaceuticals Ltd specializes in the production of tablets, capsules, and oral syrup. … Read more
Low
77
52W Range
High
216
  • Bafna Pharma
  • Jenburkt Pharma
  • Haleos Labs

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

7 Yes

Positive for this company

2 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Bafna Pharmaceuticals Ltd. Business

Bafna Pharmaceuticals Ltd specializes in manufacturing tablets, capsules, and oral syrups, focusing on prescription drugs for the global market. They offer contract manufacturing services and a wide range of pharmaceutical categories.

Bafna Pharmaceutical major competitors are Jenburkt Pharma, Haleos Labs, Aptus Pharma, Albert David, KRM Ayurveda, Valiant Laboratories, iStreet Network.
Market Cap of Bafna Pharmaceutical is ₹470 Crs.
While the median market cap of its peers are ₹403 Crs.

Bafna Pharmaceutical seems to be less financially stable compared to its competitors.
Altman Z score of Bafna Pharmaceutical is 5.32 and is ranked 4 out of its 8 competitors.

Company Filing

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material